DNMT1 and neoplasm: Having better selectivity and stability than 5‐AZA and decitabine and fewer side effects; effectively reducing the expression of DNA methyltransferase 1 (DNMT1), inhibited the level of DNA methylation, restoring the expression of relevant tumour suppressor genes and further inhibiting the expression of related oncogenes